Table 3.
Correlation between hTERT and pAkt expression, and the clinicopathological parameters in epithelial ovarian cancer patients
| hTERT expression (%) | pAkt expression (%) | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| (+) | (-) | P-value | (+) | (-) | P-value | |
| Age | ||||||
| < 55 | 34 (37.0) | 26 (28.3) | 0.969 | 42 (45.7) | 18 (19.6) | 0.242 |
| ≥ 55 | 18 (19.6) | 14 (15.2) | 26 (28.3) | 6 (6.5) | ||
| FIGO stage | ||||||
| Early (I, II) | 17 (18.5) | 15 (16.3) | 0.631 | 24 (26.1) | 8 (8.7) | 0.862 |
| Advanced (III, IV) | 35 (38.0) | 25 (27.2) | 44 (47.8) | 16 (17.4) | ||
| Histology | ||||||
| Serous | 30 (32.6) | 19 (20.7) | 0.331 | 37 (40.2) | 12 (13.0) | 0.710 |
| Non-serous | 22 (23.9) | 21 (22.8) | 31 (33.7) | 12 (13.0) | ||
| Grade | ||||||
| 1 | 8 (8.7) | 5 (5.4) | 0.694 | 2 (2.2) | 11 (12.0) | 0.045 |
| 2 or 3 | 44 (47.8) | 35 (38.0) | 66 (71.7) | 13 (14.1) | ||